Episurf Medical received a Notice of Allowance from the United States Patent and Trademark Office addressing 3D-based assessment of joint lesions. This complements an earlier patent, “System and method for creating a decision support material indicating damage to an anatomical joint,” granted in 2017.
Episealer devices treat localized cartilage damage in the knee. The portfolio includes a Damage Marking Report which creates a virtual model of the femoral knee based on MRI. This supports 3D visualization of cartilage and subchondral damage, the effects of previous surgery, presence of osteoarthritis, etc. This assessment directs pre-op surgical planning and includes a virtual, interactive 3D patient model.
Episurf Medical received a Notice of Allowance from the United States Patent and Trademark Office addressing 3D-based assessment of joint lesions. This complements an earlier patent, "System and method for creating a decision support material indicating damage to an anatomical joint," granted in 2017.
Episealer devices treat localized...
Episurf Medical received a Notice of Allowance from the United States Patent and Trademark Office addressing 3D-based assessment of joint lesions. This complements an earlier patent, “System and method for creating a decision support material indicating damage to an anatomical joint,” granted in 2017.
Episealer devices treat localized cartilage damage in the knee. The portfolio includes a Damage Marking Report which creates a virtual model of the femoral knee based on MRI. This supports 3D visualization of cartilage and subchondral damage, the effects of previous surgery, presence of osteoarthritis, etc. This assessment directs pre-op surgical planning and includes a virtual, interactive 3D patient model.
Copy to clipboard 
